Enhancing Immune Responses and Tumor Inhibition with Iron Oxide Nanoparticle Adjuvants

Adjuvants are essential for enhancing vaccine-induced immune responses, yet the number of approved adjuvants remains limited, which necessitates the development of safe, and effective options. This study identifies iron oxide nanoparticles (IONPs) as potent activators of the NF-κB and IRF signaling pathways, suggesting their potential as adjuvants. IONPs were found to promote dendritic cell maturation and activation, enhance IgG expression, and stimulate robust Th1/Th2 immune responses in mice. Furthermore, IONPs induced the proliferation of CD8+ T cells and germinal center B cells, contributing to a durable humoral immune response. Importantly, IONPs demonstrated efficacy in preventing and treating B16F10 tumors in mice. These findings position IONPs as promising candidates for future adjuvant development.

Authors

Institutions

Publication Details

Journal
Chemistry of Materials
Published
2025-05-01
DOI
https://doi.org/10.1021/acs.chemmater.5c00636
Citations
2
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
1.19

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhancing Immune Responses and Tumor Inhibition with Iron Oxide Nanoparticle Adjuvants

Ye Shen, Yongyong Shi, Xuewen Zheng, Yan-Hua Chen et al.
2 citations
Chemistry of Materials
Nanoparticle-Based Drug Delivery
1.19
article

Enhancing Immune Responses and Tumor Inhibition with Iron Oxide Nanoparticle Adjuvants

Ye Shen, Yongyong Shi, Xuewen Zheng, Yan-Hua Chen, Kefeng Pu, Zhaoxu Luo, Jingyi Qin, Min Jiang, Shengquan Liu, Jiang Li, Yiran He, Xiaochuan Ma, Yayun Gu, Xin Li
article en
2 citations

Abstract

Adjuvants are essential for enhancing vaccine-induced immune responses, yet the number of approved adjuvants remains limited, which necessitates the development of safe, and effective options. This study identifies iron oxide nanoparticles (IONPs) as potent activators of the NF-κB and IRF signaling pathways, suggesting their potential as adjuvants. IONPs were found to promote dendritic cell maturation and activation, enhance IgG expression, and stimulate robust Th1/Th2 immune responses in mice. Furthermore, IONPs induced the proliferation of CD8+ T cells and germinal center B cells, contributing to a durable humoral immune response. Importantly, IONPs demonstrated efficacy in preventing and treating B16F10 tumors in mice. These findings position IONPs as promising candidates for future adjuvant development.

Chemistry of MaterialsVol. 37(9)
University of Science and Technology of China (CN), Chinese Academy of Sciences (CN), Suzhou Institute of Nano-tech and Nano-bionics (CN)
National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions
Zero hunger
Openalex Percentile: Top 23%
Nanoparticle-Based Drug Delivery
1.19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.